FDA Adverse Event Injury Summary report: N

MLRY-HD POR FMRL 11X160MM

MDR report key: 8734346 · Received June 26, 2019

Report

Report Number
0001825034-2019-02743
Event Type
Injury
Date Received
June 26, 2019
Date of Event
June 7, 2019
Report Date
November 19, 2019
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWZ
PMA / PMN Number
K030047
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS CONFIRMED BY REVIEW OF MEDICAL RECORDS NOTING ELEVATED METAL ION LEVELS, INFLAMMATORY MARKERS QUITE ELEVATED. THERE IS SIGNIFICANT PURULENT MATERIAL AND PSEUDOTUMOR THAT WAS DEBRIDED ALONG WITH SCAR TISSUE. THE ADDITIONAL INFORMATION DOES NOT CHANGE THE RESULTS OF THE PREVIOUS INVESTIGATION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 0

REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT PATIENT PRESENTED WITH PAIN, CLUNKING AND GRINDING, AND ELEVATED METAL ION LEVELS AND DISCUSSED WITH THE SURGEON ABOUT THE POSSIBILITY OF GETTING CULTURES IF THERE WAS SIGNIFICANT PURULENT APPEARING MATERIAL. THE PATIENT WENT IN FOR SURGERY APPROXIMATELY 9 YEARS POST IMPLANTATION WHERE PURULENT APPEARING FLUID WAS ENCOUNTERED, PSEUDOTUMOR IN THE TROCHANTERIC BURSA WAS DEBRIDED AND THE METAL HEAD WAS NOTED TO BE COLD WELDED TO THE STEM. THE HEAD COMPONENT WAS UNABLE TO BE REMOVED, SO THE SURGEON IRRIGATED AND SOAKED THE HIP IN BETADINE, REDUCED AND CLOSED IN LAYERS. THE PATIENT THEN RETURNED TO THE OPERATING ROOM APPROXIMATELY 2 MONTHS LATER. DURING THE SURGERY, THE HEAD COMPONENT WAS REMOVED WITH SIGNIFICANT EFFORT. THE CUP WAS RETROVERTED AND VERTICLE AND NEEDED TO BE MEDIALIZED TO OBTAIN A GOOD FIT. SURROUNDING OSTEOLYSIS WAS NOTED AND SIGNIFICANT POSTERIOR CAPSULE WAS LOST DUE TO DEBRIDEMENT. THERE WAS ALSO SCARRING OF THE SCIATIC NERVE THAT WAS DEBRIDED AS WELL. ATTEMPTS HAVE BEEN MADE, HOWEVER ADDITIONAL INFORMATION IS UNAVAILABLE AT THIS TIME.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: ITEM #US157854 MAGNUM CUP LOT #831540, ITEM #139252 MAGNUM TAPER ADAPTER LOT #327230, ITEM #157448 MODULAR HEAD LOT #143440. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS THE DEVICES REMAIN IMPLANTED. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 -2019 -02744, 0001825034 -2019-02745, 0001825034 -2019-02746.

Description of Event or Problem · 1

IT WAS REPORTED PATIENT UNDERWENT RIGHT HIP ARTHROPLASTY. SUBSEQUENTLY APPROXIMATELY 9 YEARS POST OP THE PATIENT UNDERWENT A REVISION SURGERY DUE TO PAIN. IT WAS DISCOVERED DURING THIS SURGERY THE PATIENT HAD A SEVERE INFECTION. NO DEVICES WERE REMOVED. PATIENT IS BEING TREATED FOR THE INFECTION FOR 6 WEEKS, BEFORE ANOTHER REVISION SURGERY IS SCHEDULED. ADDITIONAL INFORMATION WAS REQUESTED HOWEVER, NONE WAS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
527135 MLRY-HD POR FMRL 11X160MM HIP PROSTHESIS KWZ ZIMMER BIOMET, INC. N/A 893820

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R